Sonoma Pharmaceuticals In...

2.26
-0.01 (-0.44%)
At close: Mar 03, 2025, 3:58 PM
2.05
-9.29%
After-hours: Mar 03, 2025, 07:27 PM EST

Sonoma Pharmaceuticals Balance Sheet Statement

Year FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10 FY09 FY08 FY07 FY06 FY05 FY03 FY02
Cash & Equivalents 3.13M 3.82M 7.4M 4.22M 3.69M 3.69M 10.07M 17.46M 7.47M 6.14M 5.48M 7.9M 3.35M 4.37M 6.26M 1.92M 18.82M 19.05M 7.45M 3.29M 177K 764K
Short-Term Investments n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Long-Term Investments n/a n/a n/a n/a n/a n/a n/a n/a n/a 4.54M 10.15M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Long-Term Assets 396K 578K 707K 875K 850K 1.23M 1.82M 1.58M 65K 68K 128K 231K 72K 53K 60K 73K 359K 875K 522K 100K n/a n/a
Receivables 2.9M 2.57M 2.41M 2.81M 3.97M 3.48M 1.54M 2.11M 1.51M 1.52M 2.33M 1.71M 2.16M 2.12M 1.42M 923K 770K 1.36M 1.8M 227K n/a n/a
Inventory 2.72M 2.86M 2.66M 2.53M 2.19M 3.41M 2.87M 2.22M 1.64M 1.4M 1.09M 992K 953K 733K 565K 340K 259K 282K 317K 868K n/a n/a
Other Current Assets 3.8M 4.55M 3.96M 3.43M 2.44M 1.92M 1.79M 853K 2.32M 592K 647K 935K 497K 587K 811K 758K 1.1M 3.17M 664K 499K n/a n/a
Total Current Assets 12.55M 13.8M 16.43M 12.98M 12.38M 12.5M 16.25M 22.64M 12.89M 9.65M 9.54M 11.53M 6.96M 7.81M 9.05M 3.94M 20.95M 23.87M 10.23M 4.88M 177K 764K
Property-Plant & Equipment 651K 906K 879K 1.13M 1.33M 727K 1.14M 1.24M 850K 795K 971K 800K 806K 802K 1.11M 1.43M 2.3M 2.21M 1.94M 1.96M n/a n/a
Goodwill & Intangibles n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Total Long-Term Assets 2.19M 2.43M 2.42M 2M 2.18M 1.95M 2.95M 2.82M 915K 5.4M 11.25M 1.03M 878K 855K 1.17M 1.5M 2.66M 3.08M 2.46M 2.06M n/a n/a
Total Assets 14.74M 16.23M 18.84M 14.99M 14.56M 14.45M 19.21M 25.46M 13.8M 15.05M 20.79M 12.56M 7.84M 8.66M 10.22M 5.45M 23.61M 26.95M 12.69M 6.94M 961K 1.69M
Account Payables 607K 841K 1.64M 1.77M 2.07M 1.25M 1.27M 1.25M 1.34M 932K 736K 808K 816K 669K 981K 1.56M 2.98M 2.55M 2.77M 906K n/a n/a
Deferred Revenue 478K 160K 1.28M 319K 273K 102K 206K 521K 574K 769K 2.63M 2.32M 1.62M 1.81M 328K 425K 523K n/a 156K 1.5M n/a n/a
Short-Term Debt 719K 943K 1.06M 1.08M 615K 463K 377K 197K 114K 87K 143K 1.26M 1.42M 907K 204K 267K 2.01M 6.06M 519K 977K n/a n/a
Other Current Liabilities -2.79M -2.46M -2M -2.56M 2.47M 1.77M 2M 1.92M 2.1M 793K 4.06M 684K 778K 1.03M 1.23M 847K 2.46M 1.42M 1.65M 2.33M n/a n/a
Total Current Liabilities 3.72M 3.72M 5.82M 4.08M 4.87M 3.59M 3.26M 3.29M 3.55M 2.58M 7.57M 5.13M 4.75M 4.42M 2.73M 2.68M 7.45M 10.03M 5.1M 4.22M n/a n/a
Long-Term Debt 87K 162K 309K 1.84M 235K 12K 176K 213K n/a n/a 4K 676K 1.82M 1.64M 110K 74K 211K 2.02M 251K 520K n/a n/a
Other Long-Term Liabilities 4.71M 4.24M 3.84M 3.48M 3.73M n/a n/a n/a n/a n/a n/a 62K 2M 750K n/a n/a n/a n/a n/a n/a n/a n/a
Total Long-Term Liabilities 4.88M 4.54M 4.33M 5.55M 991K 368K 619K 740K 112K 413K 1.16M 3.36M 3.96M 2.55M 438K 499K 734K 2.02M 251K 520K n/a n/a
Total Liabilities 8.6M 8.25M 10.15M 9.62M 5.86M 3.96M 3.88M 4.03M 3.66M 2.99M 8.73M 8.48M 8.71M 6.96M 3.17M 3.18M 8.18M 12.05M 5.35M 4.74M 1.04M n/a
Total Debt 608K 849K 1.37M 2.67M 1.48M 475K 553K 410K 114K 87K 147K 1.94M 3.24M 2.54M 314K 335K 2.22M 8.08M 770K 1.5M n/a n/a
Common Stock 2K 5K 2K 2K 2K 2K 1K 1K 2K 2K 1K 1K 3K 3K 3K 2K 2K 1K 3.4M 3.1M n/a n/a
Retained Earnings -194.35M -189.51M -184.36M -179.28M -172.25M -169.24M -157.44M -143.1M -152.38M -142.21M -134.01M -137.75M -132.31M -124.98M -117.04M -108.48M -90.83M -70.49M -50.3M -27.08M n/a n/a
Comprehensive Income -2.72M -3.42M -4.31M -4.58M -5.61M -4.35M -3.98M -4.18M -3.85M -3.51M -3.07M -2.99M -3.05M -2.9M -2.99M -3.05M -2.77M -364K -795K -817K n/a n/a
Shareholders Equity 6.14M 7.98M 8.7M 5.36M 8.71M 10.49M 15.33M 21.43M 10.14M 12.05M 12.06M 4.08M -868K 1.7M 7.04M 2.27M 15.43M 14.9M 7.34M 2.2M -79K 940K
Total Investments n/a n/a n/a n/a n/a n/a n/a n/a n/a 4.54M 10.15M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a